Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Priority Review in RET Fusion+ NSCLC and Thyroid Cancers, Breakthrough Status in MDS, and More

January 30th 2020

MCL: FDA Approval of a Second-Generation BTK Inhibitor

January 30th 2020

CAR T-Cell Therapy and the Future Management of MCL

January 30th 2020

Mantle Cell Lymphoma: Chemotherapy-Free Treatment Options

January 30th 2020

BTK Inhibitors in MCL: AEs, Specificity, and Interactions

January 30th 2020

Selecting a BTK Inhibitor for Mantle Cell Lymphoma

January 30th 2020

Updates in Management of Mantle Cell Lymphoma

January 30th 2020

Real-World Study Shows High Rates of Endocrinopathies Are Linked to Immune Checkpoint Inhibitors

January 29th 2020

Use of immune checkpoint inhibitors correlates with high incidence of endocrinopathies, especially anti–CTLA-4 therapy.

Novel Agents Under Investigation for AML

January 28th 2020

Immune Checkpoint Inhibitors for AML

January 28th 2020

Gemtuzumab Ozogamicin for CD33+ AML and APL

January 28th 2020

Differentiation Syndrome and IDH1/2 Inhibitors

January 28th 2020

IDH1/2 Inhibitors in AML

January 28th 2020

Relapsed/Refractory FLT3-Mutated AML

January 28th 2020

Second-Generation FLT3 Inhibitors for AML

January 28th 2020

Previously Untreated FLT3-Mutated AML

January 28th 2020

CPX-351 for Secondary AML

January 28th 2020

Venetoclax-Based Chemotherapy Combinations in AML

January 28th 2020

Managing Venetoclax-Associated Toxicity in AML

January 28th 2020

Venetoclax-Based Regimens for Unfit Patients with AML

January 28th 2020